Effect of Statins on Renal Function in Chronic Kidney Disease Patients

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Dyslipidemia is a known risk factor for glomerular injury.
• The impact of statin therapy on the progression of chronic kidney disease (CKD) remains a subject of ongoing debate.
• Understanding statins' renal protective effects is crucial for managing CKD patients.

Purpose of the Study:

• To investigate the efficacy of statins in providing renal protection for patients diagnosed with chronic kidney disease (CKD).
• To analyze the association between statin use and the rate of CKD progression.

Main Methods:

• A retrospective cohort study involving 3441 patients with CKD across multiple medical centers.
• Patients were divided into two groups: statin users and non-users.
• CKD progression was defined as an average annual estimated glomerular filtration rate (eGFR) decline >5 mL/min/1.73 m² or initiation of dialysis.

Main Results:

• The adjusted odds ratio (OR) for CKD progression among statin users compared to non-users was 0.80 (95% CI 0.63-1.01).
• Statin therapy demonstrated a significant protective effect in patients with CKD stages 3B-5 (OR 0.68, 95% CI 0.48-0.95).
• A significant benefit was observed in patients with proteinuria ≥1000 mg/day (OR 0.63, 95% CI 0.43-0.92), but not in those with lower proteinuria levels.

Conclusions:

• Statin use may be associated with a reduced risk of CKD progression, particularly in patients with more advanced kidney disease (stages 3B-5) and significant proteinuria.
• Further research is warranted to confirm these findings and elucidate the mechanisms behind statins' renal protective effects in specific CKD subpopulations.